GOSS Short Sellers Retreat Amid Biotech Turbulence
Gossamer Bio shares tumbled 19% this week to $0.36, tracking analysts' bearish pivot after disappointing trial data. Short interest fell 3% week-over-week to 15.4% of float, while borrowing costs eased and utilisation…
